Published in Probl Tuberk on January 01, 1997
Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis. PLoS One (2016) 0.75
[New microbiological Techniques in diagnosis of tuberculosis]. Probl Tuberk (1996) 1.13
Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips. Bull Exp Biol Med (2008) 1.11
CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol (2004) 0.93
Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis (2012) 0.93
Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. Eur J Clin Microbiol Infect Dis (2010) 0.90
[Examining the ex vivo growth in the macrophages of Mycobacterium tuberculosis of various genotypic clusters]. Probl Tuberk Bolezn Legk (2006) 0.90
Serodiagnosis of tuberculosis: detection of mycobacterial antibodies and antigens. Tuber Lung Dis (1996) 0.87
[Genotypic characteristics of Mycobacterium tuberculosis strains from the Republic of Tyva]. Probl Tuberk Bolezn Legk (2004) 0.84
[Molecular genotyping of Mycobacterium tuberculosis strains isolated from patients in the Samara region by the restriction DNA fragment length polymorphism]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.83
Detection of rifampicin-resistant Mycobacterium tuberculosis strains by hybridization and polymerase chain reaction on a specialized TB-microchip. Bull Exp Biol Med (2001) 0.81
Association of various genetic markers with tuberculosis and other lung diseases in Tuvinian children. Tuber Lung Dis (1996) 0.81
Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae. Clin Exp Immunol (2006) 0.81
[Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia]. Mol Gen Mikrobiol Virusol (2000) 0.79
[Determination of multidrug resistance of M. tuberculosis by different methods]. Probl Tuberk Bolezn Legk (2006) 0.79
[Organization of antituberculous care in penitentiary facilities]. Probl Tuberk Bolezn Legk (2004) 0.78
[Tuberculous IgE antibodies. Part II. Study of its concentrations in different forms of tuberculosis]. Probl Tuberk (2002) 0.77
[Anti-tuberculous IgE antibodies. I. Immunodominant antigens]. Probl Tuberk (2002) 0.77
[Experimental approaches to designing vaccines against tuberculous infection reactivation]. Probl Tuberk Bolezn Legk (2006) 0.77
[Impact of M. tuberculosis genotype on survival in mice with experimental tuberculosis]. Probl Tuberk Bolezn Legk (2007) 0.77
[A locus involved in tuberculosis infection control in mice locates in the proximal part of the H2 complex]. Mol Biol (Mosk) (2011) 0.77
[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region]. Probl Tuberk Bolezn Legk (2006) 0.77
[Mycobacterium tuberculosis strain transmission caused by migratory processes in the Russian Federation (in case of populational migration from the Caucasian Region to Moscow and the Moscow Region)]. Probl Tuberk Bolezn Legk (2006) 0.76
Endogenous fragment of hemoglobin, neokyotorphin, as cell growth factor. Peptides (2001) 0.76
[Biological properties of M. Tuberculosis W cluster strains]. Probl Tuberk Bolezn Legk (2008) 0.76
New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth. Acta Naturae (2010) 0.75
[Comparative characterization of the antigenic composition of M. leprae and M. lufu]. Probl Tuberk (2001) 0.75
[Molecular epidemiology of tuberculosis]. Probl Tuberk Bolezn Legk (2007) 0.75
[Identification of mycobacteria in sputum by determining antigens in the culture medium]. Probl Tuberk (1994) 0.75
Effect of exogenous cardiolipin on the growth and viability of Mycobacterium tuberculosis H37Rv in vitro. Dokl Biol Sci (2010) 0.75
[Experience with fenazid in perperas with respiratory tuberculosis and post-tuberculous changes in the lung]. Probl Tuberk Bolezn Legk (2004) 0.75
[Antimycobacterial activity of a dry birch bark extract on a model of experimental pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Serological and immunochemical properties of carbohydrate-containing fraction from mycobacterium tuberculosis H37Rv]. Probl Tuberk (1998) 0.75
[Preparation and characteristics of murine monoclonal antibodies to the Salmonella typhimurium K-antigen]. Biull Eksp Biol Med (1994) 0.75
[The comparative cultural-biochemical and immunochemical identification of laboratory strains of cultured mycobacteria from leprous patient lesions and from soil]. Probl Tuberk (2000) 0.75
[Humoral immune response in humans and animals infected and immunized with Mycobacteria of the MAIS complex]. Probl Tuberk (1994) 0.75
Effects of liposomes of different lipid composition on in vitro growth of Mycobacterium tuberculosis H37Rv. Bull Exp Biol Med (2009) 0.75
[Changes of immune and non-specific reactivity in patients with chronic suppurative obstructive bronchitis in comprehensive treatment with thymogen]. Probl Tuberk (1994) 0.75
[Immunologic and non-specific reactivity in patients with chronic suppurative obstructive bronchitis and its effect on the course of disease]. Probl Tuberk (1994) 0.75
[Use of immunochemical studies to predict the course of fibrous cavernous tuberculosis of lung and postoperative complications in patients on chemo and laser therapy]. Probl Tuberk (1997) 0.75
[Production and characteristics of monoclonal antibodies reacting with human-type M. tuberculosis]. Probl Tuberk (1990) 0.75
[Characterization of an experimental model of endogenously reactivated tuberculosis: detection of Mycobacterial DNA during chemotherapy]. Probl Tuberk (2002) 0.75
[S and R forms of Mycobacterium tuberculosis as a problem of producing cloned and phenotypically competent strains]. Probl Tuberk (1996) 0.75
[Principles and methods of immunodiagnosis in tuberculosis]. Vestn Ross Akad Med Nauk (1995) 0.75
[A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Chemotherapy of tuberculosis: problems and perspectives]. Vestn Ross Akad Med Nauk (2012) 0.75
[Regulatory effect of complex of natural cytokines and antimicrobial peptides on murine macrophages infected with multidrug-resistant Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.75
[Detection of mutations in codon 306 of the embB gene for molecular genetic characterization of clinical Mycobacterium tuberculosis strains]. Probl Tuberk Bolezn Legk (2009) 0.75
[Detection of Mycobacterial antigens in tuberculous pleuritis, empyema and meningitis]. Probl Tuberk (1995) 0.75
[Development of pulmonary chlamydia infection in inbred mice lines differentiated by genetically determinated sensitivity to tuberculosis infection]. Mol Gen Mikrobiol Virusol (2010) 0.75
[The practical use of monoclonal antibodies to Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Study of characteristics of the antigen structure of different mycobacteria (epitope mapping) with monoclonal antibodies]. Biull Eksp Biol Med (1998) 0.75
[Advances in microbiological diagnosis of tuberculosis and sarcoidosis]. Probl Tuberk (1996) 0.75
[Symposium "Immunodiagnosis and pathogenesis of Mycobacterial diseases"]. Probl Tuberk (1994) 0.75
[Biological characteristics of M. tuberculosis and difficulties in microbiological diagnosis of tuberculosis]. Probl Tuberk (1995) 0.75
[Biological properties of M. leprae passaged in laboratory animals]. Probl Tuberk (1995) 0.75
[The use of allele-specific amplification and analysis of conformational polymorphism for detection of rifampicin resistance in clinical isolates of Mycobacterium tuberculosis]. Biull Eksp Biol Med (1999) 0.75
[Significance of molecular genetic and immunological techniques in risk groups and in children with tuberculosis]. Probl Tuberk (2003) 0.75
[Characteristics of abacillary tuberculosis in school-age children and adolescents and laboratory methods of its diagnosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Role of PCR analysis in complex bacteriological studies in phthisiology]. Probl Tuberk (2001) 0.75
[The level of cytokines in the ex vivo infection of murine macrophages with Mycobacterium tuberculosis complex]. Probl Tuberk Bolezn Legk (2009) 0.75
[Microbiological diagnosis of tuberculosis]. Vestn Ross Akad Med Nauk (1995) 0.75
[Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation]. Probl Tuberk Bolezn Legk (2007) 0.75
[Improving the efficacy of tuberculosis immunodiagnosis using anti-human IgG monoclonal antibodies]. Klin Lab Diagn (1999) 0.75
[Detection of antituberculosis antibodies and antigens by enzyme immunoassay in young and preschool children suffering from tuberculosis]. Probl Tuberk (1998) 0.75
[Improving of methods of production and screening of monoclonal antibodies to Salmonella antigens]. Klin Lab Diagn (1995) 0.75
[Comparative characterization of molecular and microbiological methods for controlling chemotherapy in new cases of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Probl Tuberk Bolezn Legk (2004) 0.75
[Screening of human and animal tissue cell cultures as potential producers of plasminogen activator]. Antibiot Med Biotekhnol (1986) 0.75
[Diagnosis of latent primary intrathoracic tuberculosis of respiratory system in the phase of calcification in children]. Probl Tuberk Bolezn Legk (2004) 0.75
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Probl Tuberk Bolezn Legk (2006) 0.75
[Mycobacterial antigens and antitubercular antibodies in patients with tuberculosis salpingo-oophoritis]. Probl Tuberk (1997) 0.75
[Detection and characteristics of rpoB gene mutations in rifampicin-resistant clinical strains of M. tuberculosis]. Probl Tuberk (1999) 0.75
[Dynamics in bacterial isolation and antigenemia in patients with infiltrative pulmonary tuberculosis]. Probl Tuberk (1994) 0.75
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis]. Probl Tuberk (2002) 0.75
[Inhibiting effect of complex of natural cytokines and cationic antimicrobial peptides on the growth of Mycobacterium tuberculosis H37Rv in vitro]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[The RH-PA cell line--a source for obtaining the urokinase-type plasminogen activator]. Antibiot Khimioter (1989) 0.75
[Affinity isolation of mycobacterial antigens on monoclonal antibodies]. Probl Tuberk (1995) 0.75
[Synthesis and biological properties of α-thymidine 5'-aryl phosphonates]. Bioorg Khim (2015) 0.75
[A genotypic study of children ill with tuberculosis and of healthy BCG-revaccinated ones of Tuvinian nationality]. Probl Tuberk (1993) 0.75
[The isolation and characteristics of monoclonal antibodies to Mycobacterium smegmatis and M. kansasii]. Probl Tuberk (1996) 0.75
[Radioimmunologic and immunoenzyme methods of analysis of anti-tuberculosis antibodies]. Probl Tuberk (1988) 0.75
[Genotyping mycobacteria, isolated from incarcerated tuberculosis patients]. Probl Tuberk (2001) 0.75
[Comparative analysis of the effects of the unpurified preparations of murine erythropoietin and human recombinant erythropoietin on erythroid and granulocyte-macrophage progenitor cells in semi-solid mouse bone marrow cultures]. Biull Eksp Biol Med (1991) 0.75
[Examining of humoral immunity on mycobacteria antigens in sarcoidosis]. Probl Tuberk (1997) 0.75